Researchers believe that GLP1 receptor activation may reduce airway inflammation by: Modulating immune responses, including dampening the activity of inflammatory cells like eosinophils and T-helper cells Lowering oxidative stress, which damages airway tissues Potentially affecting smooth muscle responsiveness in the airways These effects suggest that GLP1 therapies could play a beneficial role in asthma symptom controlespecially for patients with overlapping metabolic issues
Skipping titration steps or increasing doses too quickly is the most common reason patients experience more intense side effects than necessary
Since this study was retrospective, it demonstrates association but not causation between GLP-1 medications and colorectal cancer risk
The initial approval of SGLT-2i and GLP-1RA as glucose-lowering drugs for T2D has likely impeded their uptake by cardiologists, who tend to consider glycemic control and HbA1c targets as outside of their therapeutic scope
Among the various specifications associated with LiPo batteries, the C rating stands out as a crucial factor that directly influences their performance
Experts predict it may scale to a whopping $32.24 billion over the next decade
